• Profile
Close

Etoposide as a single agent in the treatment of mycosis fungoides: A retrospective analysis

Dermatologic Therapy Apr 18, 2018

Purnak S, et al. - Experts reviewed their experience with single-agent etoposide in the treatment of advanced-stage or refractory early-stage mycosis fungoides (MF) with focus on analyzing its efficacy and safety. They identified patients through the Cutaneous T Cell Lymphoma Database of Indiana University that involved patients treated from 2006 to 2016. Findings demonstrated that for MF, etoposide was an effective treatment and could be considered in selected patients with progressive MF who failed other treatments.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay